Skip to content

Dr. Lupo Antonella

Orthoptist / Assistant in Ophthalmology
FondazioneBietti_Lupo Antonella
Research line: Glaucoma and anterior segment with ocular annexes
Research unit: RU Glaucoma
Simple Operating Unit: Simple Operating Unit Glaucoma and Hospital-Territory Integration 
Main specializations: REFRACTIVE ERRORS, GLAUCOMA, LOW VISION AND VISUAL REHABILITATION

E-mail: antonella.lupo@fondazionebietti.it

06/19/2021. 1st level Master in “New techniques and strategies of visual rehabilitation”. University of Rome “La Sapienza”

20/05/2019. Advanced course in low vision and visual rehabilitation for adults: “Qualified expert in low vision”. International School of Optics and Optometry (S.I.O.O)

19/03/2016. 1st level Master in “Assistance in ophthalmic surgery”University of Rome – “La Sapienza”

14/11/2014. 1st level degree in “Orthoptics and assistance in ophthalmology”. University of Rome “TorVergata” Faculty of Medicine and Surgery.

  • 2022 to date Permanent employee as Orthoptist and assistant in ophthalmology at IRCCS G.B. Bietti
  • 2016/2021 Contractor as orthoptist and assistant in ophthalmology at IRCCS G.B. Bietti

2022 to date Permanent employee as Orthoptist and assistant in ophthalmology at IRCCS G.B. Bietti

Sub-Investigator of the following clinical trials:

  • Modulazione della connettività neuronale lungo le vie ottiche nei pazienti glaucomatosi tramite trattamento con citicolina in soluzione orale: studio morfo-funzionale multimodale
  • Efficacy and  safety  assessment  of  T4030  eye  drops  versusGanfort® UD  in  ocular  hypertensive or glaucomatous patients. LT4030-301
  • A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension TRITON 1698-301-007
  • Basic human research studyof novel glaucoma endpoints and identification of optimal patient populations forneuroprotection trials CBASICHR0031
  • Valutazione della spatial summation nei 10 gradi centrali del campo visivo: sviluppo di un modello neurale per analisi struttura – funzione
  • Efficacia nelle 24 ore e tollerabilità dell’associazione fissa tafluprost –timololo senza conservanti nei pazienti glaucomatosi o ipertesi oculari già in trattamento con latanoprost conservato con BAK. Studio prospettico in aperto della durata di 3 mesi. HERO
  • Valutazione dell’agreement nella diagnosi di progressione campimetrica del glaucoma
Skip to content